Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Deep Ensemble for the Recognition of Malignancy (DERM) | Device | An AI-based diagnosis support tool |
| Measure | Description | Time Frame |
|---|---|---|
| Sensitivity of DERM to detect "Malignant conditions" | Sensitivity of DERM to detect Melanoma, SCC and BCC combined | Through study completion, on average of 1 day |
| Specificity of DERM to detect Malignant conditions. | Specificity of DERM to detect Melanoma, SCC and BCC combined | Through study completion, on average of 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Sensitivity of DERM to detect Melanoma | Sensitivity of DERM to detect Melanoma | Through study completion, on average of 1 day |
| Specificity of DERM to detect Melanoma | Specificity of DERM to detect Melanoma |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic accuracy measures | AUROC, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) etc. of DERM to detect melanoma, SCC, BCC, premalignant, and benign conditions grouped and individually | Through study completion, on average of 1 day |
| Probability that the most probable lesion label DERM returns matches the lesion diagnosis |
Inclusion Criteria:
To be suitable for inclusion, a skin lesion must NOT have ANY of the following limitations:
located on an anatomical site of different skin structure: palms of hands or soles of feet (acral lesion), mucosal surfaces (lips and eyes) or under nail (ungal lesion), a diameter greater than the diameter of the dermoscopic lenses, located on an anatomical site unsuitable for photographing, including on surface of genitals and hair-bearing areas, has been previously biopsied, excised, treated or otherwise traumatised, located in an area of visible scarring or tattooing.
- In the Investigator's opinion, able and willing to comply with all study requirements.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients attending a dermatology clinic with at least one skin lesion that will be biopsied due to a suspicion of skin cancer will be eligible for the study.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford university | Redwood City | California | 94063 | United States | ||
| Vista Health Research, LLC |
Not provided
Not provided
Not provided
Not provided
| Through study completion, on average of 1 day |
| Sensitivity of DERM to detect Squamous Cell Carcinoma | Sensitivity of DERM to correctly classify SCC | Through study completion, on average of 1 day |
| Specificity of DERM to detect Squamous Cell Carcinoma | Specificity of DERM to correctly classify SCC | Through study completion, on average of 1 day |
| Sensitivity of DERM to detect Basal Cell Carcinoma | Sensitivity of DERM to correctly classify BCC | Through study completion, on average of 1 day |
| Specificity of DERM to detect Basal Cell Carcinoma | Specificity of DERM to correctly classify BCC | Through study completion, on average of 1 day |
| Accuracy of mole/not mole algorithm | Accuracy of mole/not mole algorithm | Through study completion, on average of 1 day |
Probability that the alternative classification label DERM that returns, matches the lesion diagnosis |
| Through study completion, on average of 1 day |
| The impact of patient characteristics on the diagnostic accuracy of DERM | Such as sex, age, and Fitzpatrick skin type | Through study completion, on average of 1 day |
| The impact of lesions characteristic on the diagnostic accuracy of DERM | Such as location, size, growth, stage and sub-type | Through study completion, on average of 1 day |
| AUROC of DERM to identify malignant conditions for each individual camera / lens type | AUROC of DERM to identify malignant conditions for each individual camera / lens type | Through study completion, on average of 1 day |
| Concordance of DERM results by each individual camera / lens type | Concordance of DERM results by each individual camera / lens type | Through study completion, on average of 1 day |
| Strength of association between correct classification and acceptance/rejection status of images | Strength of association between correct classification and acceptance/rejection status of images | Through study completion, on average of 1 day |
| AUROC of DERM when macro images are used both to train the algorithm and as test images | AUROC of DERM when macro images are used both to train the algorithm and as test images | Through study completion, on average of 1 day |
| Correlation between clinician assessment of likelihood of skin cancer with histopathology diagnosis | Correlation between clinician assessment of likelihood of skin cancer with histopathology diagnosis | Through study completion, on average of 1 day |
| Percentage of images taken that are rejected by the IQ check (MoleNotMole + Image Quality), where a second image is successfully taken | Percentage of images taken that are rejected by the IQ check (MoleNotMole + Image Quality), where a second image is successfully taken | Through study completion, on average of 1 day |
| Miami |
| Florida |
| 33176 |
| United States |
| Dorisca Research Consulting, LLC | Miami | Florida | 34761 | United States |
| Northwestern University | Chicago | Illinois | 60208 | United States |
| ALLCUTIS Research, LLC | Beverly | Massachusetts | 01915 | United States |
| Allcutis Research | Methuen | Massachusetts | 01844 | United States |
| Universal Dermatology, PLLC | Fairport | New York | 14450 | United States |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | United States |
| Alpesh D. Desai, DO, PLLC, a Houston company institution | Houston | Texas | 34761 | United States |
| University of Utah | Salt Lake City | Utah | 84112 | United States |
| Universitaria Di Bologna | Bologna | Italy |
| Dermatology University of Florence | Florence | 50100 | Italy |
| Università degli Studi di Modena e Reggio Emilia | Modena | Italy |
| University of Campania | Naples | 80131 | Italy |
| Università del Piemonte Orientale | Novara | 28100 | Italy |
| UOSD Dermatology Oncology | Roma | Italy |
| ID | Term |
|---|---|
| D002280 | Carcinoma, Basal Cell |
| D002294 | Carcinoma, Squamous Cell |
| ID | Term |
|---|---|
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D018295 | Neoplasms, Basal Cell |
| D018307 | Neoplasms, Squamous Cell |
Not provided
Not provided